
Sign up to save your podcasts
Or
The nature of PCOS is that there is not one single feature that characterizes the condition. Menstrual disturbance is a potential symptom, and today’s episode delves into anti-Müllerian hormone testing, how it can be used to diagnose PCOS along with the implications it has for the prognosis. Dr. Minni discusses some of the key results from an NIH study done on the AMH and explains the relationship to PCOS. We also learn about some of the advantages of this test, like its non-invasive nature and the fact it can be done at any stage of the menstrual cycle. While this test is not a conclusive diagnosis of PCOS, because it can show underlying causes of menstrual irregularities, it’s possible to use natural interventions rather than conventional medicine ones. We round the show off by discussing some of these strategies along with getting a preview of next week’s episode. Be sure to tune in today!
Key Points From This Episode:
Tweetables:
“What is this anti-Müllerian hormone and how is it produced? It is actually a member of the transforming growth factor-beta, so it’s one of the growth factors that is produced by our bodies’ member of that and is produced by growing ovarian antral follicles.” — Dr. Minni Malhotra [0:03:59]
“Remember that conventional medicine cannot be all thrown out of the window. You have to use the good parts of conventional medicine to actually make it work for you.” — Dr. Minni Malhotra [0:06:15]
“The AMH or anti-Müllerian hormone is a strong predictor for menstrual disturbance due to polycystic ovarian syndrome, and the risk of menstrual disturbance was increased with the degree of elevation of anti-Müllerian hormone.” — Dr. Minni Malhotra [0:07:05]
Links Mentioned in Today’s Episode:
Dr. Minni Malhotra Email
Anchor Wellness Center
National Institutes of Health
The nature of PCOS is that there is not one single feature that characterizes the condition. Menstrual disturbance is a potential symptom, and today’s episode delves into anti-Müllerian hormone testing, how it can be used to diagnose PCOS along with the implications it has for the prognosis. Dr. Minni discusses some of the key results from an NIH study done on the AMH and explains the relationship to PCOS. We also learn about some of the advantages of this test, like its non-invasive nature and the fact it can be done at any stage of the menstrual cycle. While this test is not a conclusive diagnosis of PCOS, because it can show underlying causes of menstrual irregularities, it’s possible to use natural interventions rather than conventional medicine ones. We round the show off by discussing some of these strategies along with getting a preview of next week’s episode. Be sure to tune in today!
Key Points From This Episode:
Tweetables:
“What is this anti-Müllerian hormone and how is it produced? It is actually a member of the transforming growth factor-beta, so it’s one of the growth factors that is produced by our bodies’ member of that and is produced by growing ovarian antral follicles.” — Dr. Minni Malhotra [0:03:59]
“Remember that conventional medicine cannot be all thrown out of the window. You have to use the good parts of conventional medicine to actually make it work for you.” — Dr. Minni Malhotra [0:06:15]
“The AMH or anti-Müllerian hormone is a strong predictor for menstrual disturbance due to polycystic ovarian syndrome, and the risk of menstrual disturbance was increased with the degree of elevation of anti-Müllerian hormone.” — Dr. Minni Malhotra [0:07:05]
Links Mentioned in Today’s Episode:
Dr. Minni Malhotra Email
Anchor Wellness Center
National Institutes of Health